According to Newbury Pharmaceuticals AB latest financial reports the cash on hand of NEWBRY is $835.38K, an decrease of -74.42% to 2022. At the end of 2022 company had $3.27M cash on hand. This amount reflects the liquid assets available to the company, which are crucial for its operational flexibility, investment opportunities, and overall financial security.
Year | Cash on Hand | Change |
---|---|---|
2023 | $835.38K | -74.42% |
2022 | $3.27M | 153.59% |
2021 | $1.29M | - |